Tag "AlzeCure"

Back to homepage
NEWS

AlzeCure presents positive preclinical efficacy data for the TrkA-NAM pain project

AlzeCure Pharma, a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, recently announced